TOKYO--(BUSINESS WIRE)--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, is pleased to announce that its proprietary probiotic strain Bifidobacterium longum subsp. longum BB536 (hereafter referred to as Bifidobacterium longum BB536) has obtained approval from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, ANVISA).

东京-（商业电线）-日本领先的乳制品公司森永乳业有限公司（东京：2264）很高兴地宣布其专有的益生菌菌株长双歧杆菌亚种。longum BB536（以下称为长双歧杆菌BB536）已获得巴西卫生监管机构（AgênciaNacional deVigilânciaSanitária，ANVISA）的批准。

This approval, granted on July 27, 2023, allows for the utilization of Bifidobacterium longum BB536 in dietary supplements and conventional food products sold in Brazil. The strain has also been registered in ANVISA’s list of approved products..

该批准于2023年7月27日获得批准，允许在巴西销售的膳食补充剂和常规食品中使用长双歧杆菌BB536。该菌株也已在ANVISA的批准产品清单中注册。。

Bifidobacterium longum BB536, a clinically effective and well-established multifunctional probiotic strain, has a history of over 50 years of human use, supported by more than 240 scientific studies as of March 2023. Bifidobacterium longum BB536 has been recognized globally as a leading functional probiotic ingredient, holding Generally Recognized as Safe (GRAS) status in the U.S.

长双歧杆菌BB536是一种临床有效且成熟的多功能益生菌菌株，已有50多年的人类使用历史，截至2023年3月，已有240多项科学研究支持。长双歧杆菌BB536已被全球公认为主要的功能性益生菌成分，在美国被公认为安全（GRAS）状态。

for use in conventional foods and infant formula. It has also been approved as a 'New Food Ingredient' in China for use in infant and toddler foods under the age of three..

用于常规食品和婴儿配方奶粉。它还被批准为中国的“新食品配料”，用于三岁以下的婴幼儿食品。。

This recent approval by ANVISA allows Bifidobacterium longum BB536 to be used in dietary supplements and various conventional foods. At the same time, it is approved to claim that 'Bifidobacterium longum BB536 may contribute to the health of the gastrointestinal tract.'

ANVISA最近的批准允许长双歧杆菌BB536用于膳食补充剂和各种常规食品。同时，批准声称“长双歧杆菌BB536可能有助于胃肠道的健康”

The approval holds significant implications for Morinaga Milk's global growth strategy. As one of the objectives outlined in the company's 10-year vision, Morinaga Milk aims to achieve an overseas sales ratio of at least 15% by the fiscal year ending March 31, 2029. This approval aligns with the company's commitment to expanding its presence in international markets, including strengthening partnerships with major infant formula manufacturers and sales for dietary supplements all over the world..

该批准对Morinaga Milk的全球增长战略具有重要意义。作为该公司10年愿景中概述的目标之一，森永乳业的目标是在截至2029年3月31日的财政年度之前实现至少15%的海外销售比率。这一批准符合该公司扩大其在国际市场的承诺，包括加强与主要婴儿配方奶粉制造商的合作关系以及全球膳食补充剂的销售。。

The Brazilian probiotic supplement market is growing rapidly, with a compound annual growth rate of approximately 9% from 2013 to 2022, and the market size has more than doubled to approximately US$200 million*1. Morinaga Milk anticipates a promising future in the Brazilian market.

巴西益生菌补充剂市场增长迅速，2013年至2022年复合年增长率约为9%，市场规模翻了一番多，达到约2亿美元*1。Morinaga牛奶预计巴西市场前景广阔。

*1Source: Euromonitor International, August 2023

*来源：Euromonitor International，2023年8月

'We are thrilled to announce the approval of BB536 by ANVISA for use in supplements and conventional foods in Brazil,' stated Dr. Yoshihiko Ushida, General Manager of the International B to B Business Department of Morinaga Milk. 'This achievement underscores our commitment to producing high-quality, scientifically validated probiotics that contribute to the well-being of consumers around the world.' As Morinaga Milk moves forward, the company is enthusiastic about the opportunities presented by this milestone..

“我们很高兴宣布ANVISA批准BB536用于巴西的补充剂和传统食品，”森永牛奶国际B到B业务部门总经理Yoshihiko Ushida博士说这一成就强调了我们致力于生产高质量，经过科学验证的益生菌，有助于全世界消费者的福祉随着Morinaga牛奶向前发展，公司对这一里程碑所带来的机会充满热情。。

About Morinaga

关于森永

Morinaga Milk Industry Co., Ltd. is one of the leading dairy product companies in Japan with a century of history harnessing the nutritional properties of dairy products and functional ingredients. Morinaga Milk is also a key global probiotics manufacturer that excels in innovative technology and offers a premium line of probiotics and functional ingredients worldwide.

Morinaga Milk Industry Co.，Ltd。是日本领先的乳制品公司之一，具有利用乳制品和功能成分的营养特性的一个世纪的历史。Morinaga牛奶也是一家重要的全球益生菌制造商，在创新技术方面表现出色，并在全球范围内提供优质益生菌和功能成分。

Since the 1960s, Morinaga Milk has been engaged in research on the safety, functional health benefits, and mechanisms of action of probiotic bifidobacteria to better understand their role in maintaining human health. For more information about Morinaga Human-Residential Bifidobacteria (HRB) probiotics, please visit us at https://morinagamilk-ingredients.com/..

自20世纪60年代以来，Morinaga牛奶一直致力于研究益生菌双歧杆菌的安全性，功能健康益处和作用机制，以更好地了解它们在维持人类健康中的作用。有关Morinaga人类住宅双歧杆菌（HRB）益生菌的更多信息，请访问我们https://morinagamilk-ingredients.com/..